Cancer is one of the leading causes of death worldwide. According to GLOBOCAN, International Agency for Research on Cancer 2012, it is known that breast cancer is cancer with the highest percentage of new cases, at 43.3%, and percentage death due to breast cancer by 12.9%. Although the incidence of breast cancer in Asia remains lower than in North America, Western Europe, and Oceania, the rates have been increasing rapidly during the past few decades, and Asian countries now account for 40% of breast cancer cases diagnosed worldwide. Southeast Asian countries have moderate rates for breast cancer, with a higher incidence of one in Indonesia. Breast cancer morbidity and mortality increased among Indonesian women. These increased rateswere associated with higher prevalence of breast cancer risk factors such as hormonal contraceptive use and age of menarche. The purpose of this study was to determine the correlation between hormonal contraceptives use and generation of menarche with breast cancer among women in Indonesia. This study used a systematic review made by PRISMA. Searching for literature sources through online databases such as Science Direct, JSTOR, and Proquest, additional records identified through Google Scholar by using relevant keywords adjusted by inclusion and exclusion criteria. Five studies included in this review. All studies discussed breast cancer among women in several regions in Indonesia. There was a significant correlation between hormonal contraceptives use and age of menarche with breast cancer among women in Indonesia. Women may be more careful in determining the duration of hormonal contraceptive use and avoiding a lifestyle that can accelerate menarche.
Introduction
Cancer is one of the leading causes of death worldwide. In 2012, about 8.2 million deaths caused by the disease. According to the World Health Organization(WHO), cancer was one cause of death worldwide and an estimated 84 million people died from cancer in the period 2005 to 2015 [1] .
According to GLOBOCAN, International Agency for Research on Cancer (IARC) 2012, it is known that breast cancer is cancer with the highest percentage of new cases, at 43.3%, and percentage death due to breast cancer by 12.9% [2] . Breast cancer is a group of cells abnormally, and multiple growing in breast tissue and is the most common malignant disease found in the female group [3] . Breast cancer is a malignancy in breast tissue that can originate from the ductal epithelium or lobules [4] .
In America, there are about 92/100.000 women with breast cancer, with 27/100.000 mortality or 18% of deaths found in women [4] . Although the incidence of breast cancer in Asia remains lower than in North America, Western Europe, and Oceania, rates have been increasing rapidly during the past few decades, and Asian countries now account for 40% of breast cancer cases diagnosed worldwide [5] . The incidence of breast cancer is higher in developed countries, but the mortality is around69% in developing countries [6] . Southeast Asian countries have moderate rates for breast cancer, with a higher incidence of one in Indonesia [5] .
Breast cancer is one of the most cancer types in Indonesia. Based on pathological based registration in Indonesia, breast cancer ranks first with a relative frequency of 18.6%. Data of cancer in Indonesia in 2010, according to histopathological data; Cancer Registration Agency Association of Indonesian Pathology Specialists and Cancer Foundation Indonesia estimated the number of incidence in Indonesia is 12 /100.000 women. More than 80% of cases are found to be in an advanced stage [4] .
Breast cancer morbidity and mortality increased among Indonesian women. In the Dharmais Cancer Hospital, the number of new cases and death from breast cancer has risen by four years in a row. In 2010, the number of new cases was 711 cases, 93 cases of them caused death. In 2011, the number of new cases was 769 cases, 120 cases of them caused death. In 2012, the number of new cases was 809 cases, 130 cases of them caused death. And by 2013, the number of new cases was 819.217 cases of them caused death. [7] . These increased rates associated with higher prevalence of breast cancer risk factors such as hormonal contraceptive use and age of menarche. This systematic review was conducted to determine the correlation between hormonal contraceptives use and generation of menarche with breast cancer among women in Indonesia.
Methods
This study used a systematic review made by prisma 2009. Source literature search began on 10 June 2017 by electronic data based through remote.lib.ui.ac.id/lib.ui.ac.id website. The author conducted searching on Science Direct, JSTOR, and Proquest, additional records identified through Google Scholar. Keywords are Hormonal Contraception AND Age of Menarche AND Breast Cancer AND Indonesia. The criteria inclusion in this study were Indonesian and English language, Indonesia state and the journal year is the last ten years published, starting from 2007 to 2017. The criteria exclusion criteria are apart from the inclusion criteria.
From Science Direct, it's obtained 12 journals, JSTOR 12 journals, Proquest 91 journals, and google scholar 1640 memoirs. Journals screen by years 2007-2017 was 850. After identification conducted initial screening by reading the titles and abstracts, it's obtained 20 journals, and 838 journals remove because of claim, state, variable and year which were not appropriate with the topic. In the eligibility phase, eight journals were reviewed to decide whether the journals could use and authors got five journals systematically for systematic review. 
Results
Five studies included in this review. All studies discuss breast cancer among women in several regions in Indonesia. [9] .
Research by Gusti Ayu Triara Dewi and Lucia Yovita Hendrati (2015), the results of the analysis using binary logistic regression (α= 5%) indicated that the use of hormonal contraceptive (p= 0.028); OR: 3.266) and age of menarche (p= 0.031; OR: 3.492) has a significant correlation with the incidence of breast cancer in women at Dr. Soetomo Hospital [10] .
Research by Harianto, Rina Mutiara, and Hery Surachmat (2015) with case-control research designs found that the use of combination contraception pills has the risk to have breast cancer 1,864 times compare with them who don't take that pills [11] . 
Discussion

Correlation between hormonal contraceptives use and breast cancer
Contraception is one effort that can select to prevent conception and pregnancy. Based on the method, contraception divided into simple contraceptives and modern contraceptives. Modern contraception divided into four processes, namely mechanical, hormonal, chemical, and operative techniques. Hormonal methods of pill, injection, or implant.
Use of hormonal contraceptives can increase the risk of breast cancer. Such hormonal contraceptives can be pills, combination pills, and mini-pills, injections, or implants or plants [13] . The risk of breast cancer incidence associated with long-term use of hormonal contraception.
The use of oral contraceptives over extended periods causes an increased risk of breast cancer. The increased risk of breast cancer also occurs in women who use hormone therapy, such as exogenous hormones. The exogenous hormone can cause an increased risk of breast cancer. The use of hormonal contraceptives can lead to increased exposure of the hormone estrogen in the body. There is an increase in exposure to the hormone estrogen that can trigger abnormal cell growth in certain parts, such as the breast.
Correlation between age of menarche and breast cancer
Women who have first menstruation at <12 years of age have a slightly higher risk of breast cancer than women who have first menstruation >12 years of age. Increased risk The hormone estrogen helps the formation of the endometrium or mucous membranes that line the uterine wall. The endometrium still forms, but no eggs are ripe so that pregnancy can not occur. Side effects that may arise as a result of the use of this contraceptive pill are a headache, heart palpitations, weight gain, increased blood pressure, nausea, irregular menstrual bleeding, decreased milk production, and so on. Women who previously had a heart attack, cerebral hemorrhage, chest pain, blockage of blood vessels, breast cancer, and liver dysfunction. The use of oral contraceptives for long periods causes the risk of breast cancer to increase. of breast cancer is due to the duration of estrogen exposure that is longer and slightly higher.
When a woman experiences her first period, the function of ovarian cycles that production of estrogen begins. The longer a woman is exposed, the higher the risk for breast cancer she gets. In addition to being presented, the regularity of the menstrual cycle also plays a role. The balance of the period describes the frequency of exposure, so the faster a woman gets a higher exposure compared to women whose regular menstruation is slower or has a long menstrual cycle [14] .
Menarche age is too early in women, less than 12 years causing exposure to the hormone estrogen in the body to be faster. Estrogen hormone can trigger the growth of cells in certain parts of the body is not normal. The mechanism of the occurrence of breast cancer by estrogen exposure is still not known for sure due to estrogen stimulation of epithelial cell division or because of a cause by estrogen and its metabolites that directly act as mutagens that can cause cancer cells in the breast [15] .
Conclusion
There is a significant correlation between hormonal contraceptives use and age of menarche with breast cancer among women in Indonesia. The longer the duration of hormonal contraceptive use, the higher the risk of breast cancer. Women who are more at risk of breast cancer are women with a first menstrual period of fewer than 12 years. Based on the systematic review, authors have a few suggestions: women may be more careful in determining the duration of hormonal contraceptive use, avoiding a lifestyle that can accelerate menarche, need to do early detection regularly with breast selfexamination and then followed by examination mammography every year, and need understanding of prevention efforts, early diagnosis, curative or palliative treatment and good rehabilitation efforts.
